Enkephalins in hematopoiesis

Area of Science:

• Neuroendocrinology
• Immunology
• Hematology

Background:

• Neuropeptides, particularly opioid peptides, are increasingly recognized for their role in regulating hematopoiesis.
• Key hematopoietic cells and bone marrow stromal elements express neuropeptide receptors, and bone marrow cells produce opioid-like neuropeptides.
• The CD10/CALLA marker, present on various hematopoietic cells, is an endopeptidase capable of modulating neuropeptide activity.

Purpose of the Study:

• To investigate the role of opioid peptides in regulating hematopoiesis.
• To examine the effects of enkephalins, naloxone, and thiorphan on hematopoietic cell proliferation and differentiation in vitro.
• To explore the cellular mechanisms and signaling pathways involved in neuropeptide-mediated hematopoiesis.

Main Methods:

• Utilized clonal and long-term cultures of mouse bone marrow.
• Administered opioid peptides (enkephalins), an opioid antagonist (naloxone), and an endopeptidase inhibitor (thiorphan).
• Analyzed the modulation of hematopoietic cell proliferation and differentiation, considering accessory cell presence and circadian patterns.

Main Results:

• Opioid peptides, naloxone, and thiorphan demonstrated modulatory effects on hematopoietic cell proliferation and differentiation.
• Observed irregular, strain-dependent, and individual variations in dose-responses, suggesting complex cellular interactions.
• Confirmed that enkephalins bind to specific opioid receptors, initiating intracellular signaling cascades involving diacylglycerol (DAG), protein kinase C (PKC), and calcium ions (Ca++).

Conclusions:

• Neuropeptide regulation, specifically by opioid peptides, plays a significant role in controlling hematopoiesis.
• Hematopoiesis is likely integrated into a broader immuno-neuroendocrine network, potentially involving melatonin.
• The findings highlight the intricate interplay between the nervous, immune, and endocrine systems in regulating blood cell formation.